Growth Metrics

Clorox (CLX) Liabilities and Shareholders Equity (2016 - 2026)

Clorox has reported Liabilities and Shareholders Equity over the past 18 years, most recently at $6.4 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 16.76% year-over-year to $6.4 billion; the TTM value through Mar 2026 reached $23.1 billion, up 3.59%, while the annual FY2025 figure was $5.6 billion, 3.3% down from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $6.4 billion at Clorox, up from $5.6 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $6.4 billion in Q1 2026 and troughed at $5.5 billion in Q3 2024.
  • A 5-year average of $5.9 billion and a median of $5.8 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 8.25% in 2024 and later increased 16.76% in 2026.
  • Year by year, Liabilities and Shareholders Equity stood at $6.0 billion in 2022, then decreased by 2.27% to $5.9 billion in 2023, then dropped by 5.6% to $5.6 billion in 2024, then increased by 0.65% to $5.6 billion in 2025, then rose by 14.66% to $6.4 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for CLX at $6.4 billion in Q1 2026, $5.6 billion in Q4 2025, and $5.5 billion in Q3 2025.